Oxycodone Lp Bgr

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxycodone Lp Bgr (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone Hydrochloride, the active ingredient in Oxycodone Lp Bgr, is an opioid analgesic presented as a solid oral dosage form for systemic use. It is employed in the management of moderate to severe pain, particularly when other analgesics are insufficient, and is prescribed for adult patients.

GNH India supplies Oxycodone Lp Bgr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Biogaran

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxycodone Hydrochloride is an opioid that acts on the central nervous system to relieve pain in several clinical contexts.

Acute postoperative pain: Provides strong analgesia during the immediate recovery period after surgery.
Cancer‑related pain: Helps to control persistent pain associated with malignant disease.
Severe chronic non‑cancer pain: Alleviates long‑standing pain that has not responded to weaker analgesics.

How It Works

Oxycodone binds primarily to μ‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. This receptor engagement also modulates neurotransmitter release, contributing to its analgesic effect.

Side Effects

Adverse reactions to oxycodone may vary in frequency and severity.

Common Side Effects

Nausea and vomiting: Gastrointestinal upset is frequently reported.
Constipation: Reduced gastrointestinal motility is common with opioid use.
Drowsiness or sedation: May impair alertness and coordination.
Dry mouth: Reduced salivation leading to a parched sensation.
Dizziness: Light‑headed feeling, especially when standing quickly.
Pruritus: Itching without rash.

Serious or Rare Side Effects

Respiratory depression: Markedly slowed breathing that can be life‑threatening.
Severe hypotension: Dangerous drops in blood pressure.
Seizures: Uncommon but serious neurologic events.
Allergic reactions: Including rash, swelling, or anaphylaxis.
Dependence and withdrawal: Risk of physical dependence with prolonged use.
Adrenal insufficiency: Rare hormonal imbalance affecting stress response.

Precautions & Warnings

When prescribing oxycodone, clinicians should evaluate patient history and monitor for adverse outcomes.

Assess pain severity and opioid tolerance: Ensure the indication justifies opioid therapy.
Review respiratory function: Patients with compromised breathing need careful dosing.
Evaluate hepatic and renal function: Impaired metabolism may require dose adjustment.
Screen for substance use disorder: History of abuse increases risk of dependence.
Counsel on sedation and driving: Advise patients not to operate machinery while impaired.
Store at below 25°C: Keep in the original container, protect from moisture and light.

Avoid Interactions

Oxycodone can interact with several medication classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

CNS depressants (e.g., benzodiazepines, barbiturates): Combined use can cause profound respiratory depression.
MAO inhibitors: May precipitate hypertensive crisis or serotonin syndrome.
Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): Increase oxycodone plasma levels, raising overdose risk.

Moderate Interactions (Monitor Closely)

CYP2D6 inhibitors (e.g., fluoxetine, quinidine): May reduce conversion to active metabolites, affecting analgesia.
Anticholinergic agents: Can exacerbate constipation.
Diuretics: May enhance hypotensive effects.
Alcohol: Potentiates central nervous system depression.
Herbal supplements such as St. John’s wort: May alter opioid metabolism.

Frequently Asked Questions

Oxycodone Lp Bgr contains oxycodone hydrochloride, an opioid analgesic used to treat moderate to severe pain, including postoperative pain, cancer‑related pain, and chronic non‑cancer pain when other analgesics are insufficient.

Oxycodone binds to μ‑opioid receptors in the brain and spinal cord, activating inhibitory pathways that lower neuronal firing and reduce the perception of pain while also influencing neurotransmitter release.

The prescribed dose of Oxycodone Lp Bgr is individualized by the treating clinician based on the patient’s pain severity, prior opioid exposure, and overall health status; exact dosing regimens are not provided here.

Opioid use in pregnancy and lactation carries risks such as neonatal withdrawal and potential fetal harm; it should only be used when clearly needed and under strict medical supervision.

To request Oxycodone Lp Bgr, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Oxycodone offers strong μ‑opioid receptor activity and is often considered more potent than codeine or tramadol, but less potent than morphine equivalents at comparable doses. Its pharmacokinetic profile provides reliable oral absorption, making it suitable for a range of severe pain scenarios.

Store Oxycodone Lp Bgr at temperatures below 25 °C in its original packaging, protecting it from moisture, heat and direct sunlight to maintain potency and stability.

The product is formulated for oral administration; tablets or capsules are swallowed whole with water, typically under medical supervision, and dosing intervals are determined by the prescribing clinician.

Serious risks include respiratory depression, severe hypotension, dependence, withdrawal syndrome, and rare allergic reactions. Patients should be monitored closely for signs of these events, especially during dose initiation or escalation.

Individuals with known hypersensitivity to oxycodone or other opioids, those with significant respiratory depression, acute or severe asthma, or untreated severe head injury should avoid using this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 10 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.